Precision medicine in Singapore looking for solutions and collaborations - opportunities for Finnish companies
Singapore has already strong expertise in precision medicine (term used to describe approximately the same issues that are called personalized health in Finland). Government is working of defining and implementing a coordinated detailed national strategy to speed up the movement from academic research towards commercially available solutions for Singapore's needs and to offer them to the rest of the world, especially in Asia.
Many foreign commercial enterprises have used Singapore successfully as a "living lab" to co-develop and test-bed new products and business models for Asia. Both public and private actors involved in precision medicine have shown strong interest towards international collaboration in R&D and business creation. All this opens a multitude of research, innovation and business collaboration opportunities both with public and private players
Change in the market that has opened up this opportunity
The Singapore government has identified Precision Medicine (PM) as a high value, potentially disruptive technology, one which is a natural fit for a country with strengths in biomedical sciences, data management and storage, analytics and a technologically advanced healthcare system.
Singaporean's apparent proclivity to certain chronic diseases has caused alarm: Singapore has the second-highest proportion of diabetics in its population among developed countries, trailing behind the US only. Singapore's research community is deeply involved in various aspects of Precision Medicine (PM). Its research institutes and laboratories are world class. Singapore is home to many highly successful Big Pharma regional headquarters (RHQs) and manufacturing operations, but pharma research facilities have been moving out. Singapore is very open to partnership and collaboration. Many foreign commercial enterprises have leveraged multiple government initiatives and have used Singapore successfully as a "living lab" to co-develop and test-bed new products and business models for Asia.
Offerings (products, services, solutions) that are relevant to this opportunity:
- Data capture/integration/storage/management
- Drug development and therapies
If you are interested in this business opportunity, please contact: firstname.lastname@example.org